Anticancer drug discovery and pharmaceutical chemistry: a history.
There are several procedures for the chemical discovery and design of new drugs from the point of view of the pharmaceutical or medicinal chemistry. They range from classical methods to the very new ones, such as molecular modeling or high throughput screening. In this review, we will consider some historical approaches based on the screening of natural products, the chances for luck, the systematic screening of new chemical entities and serendipity. Another group comprises rational design, as in the case of metabolic pathways, conformation versus configuration and, finally, a brief description on available new targets to be carried out. In each approach, the structure of some examples of clinical interest will be shown.
Braña
Miguel F
MF
Instituto Canario de Investigación del Cáncer (ICIC), Spain. mfbrana@icic.es
Sánchez-Migallón
Ana
A
D000818:Animals; D000970:Antineoplastic Agents / Q000266:history*; D001688:Biological Products / Q000737:chemistry*; D002625:Chemistry, Organic; D002626:Chemistry, Pharmaceutical / Q000266:history*; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004354:Drug Screening Assays, Antitumor; D049673:History, 20th Century; D006801:Humans; D008956:Models, Chemical; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D013678:Technology, Pharmaceutical
D000970:Antineoplastic Agents; D001688:Biological Products; D004364:Pharmaceutical Preparations